Differential Effects of Progenitor Cell Populations on Left Ventricular Remodeling and Myocardial Neovascularization After Myocardial Infarction

Journal of the American College of Cardiology

Volumn 55, Issue 20, 2010, Pages 2232-2243

  Dubois, Christophe ^a   Liu, Xiaoshun ^b   Claus, Piet ^a   Marsboom, Glenn ^b   Pokreisz, Peter ^b   Vandenwijngaert, Sara ^b   Dépelteau, Hélène ^a   Streb, Witold ^a   Chaothawee, Lertlak ^a   Maes, Frederik ^a   Gheysens, Olivier ^a   Debyser, Zeger ^b   Gillijns, Hilde ^b   Pellens, Marijke ^b   Vandendriessche, Thierry ^b   Chuah, Marinee ^b   Collen, Desiré ^b   Verbeken, Erik ^a   Belmans, Ann ^b   Van de Werf, Frans ^a   Bogaert, Jan ^a   Janssens, Stefan ^a,b   more..

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

cell therapy; endothelial progenitor cells; left ventricular remodeling; mesenchymal stem cells; myocardial infarction

Indexed keywords

PLACENTAL GROWTH FACTOR;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; CELL POPULATION; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE REMODELING; IN VIVO STUDY; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZATION; SWINE; THERAPY EFFECT;

ANIMALS; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; LAC OPERON; MAGNETIC RESONANCE IMAGING, CINE; MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; VENTRICULAR REMODELING;

EID: 77951915214     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.10.081     Document Type: Article

References (29)

1. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
2. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
3. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
4. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
5. Dimmeler S., Burchfield J., and Zeiher A.M. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 28 (2008) 208-216
6. Freyman T., Polin G., Osman H., et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27 (2006) 1114-1122
7. Grogaard H.K., Sigurjonsson O.E., Brekke M., et al. Cardiac accumulation of bone marrow mononuclear progenitor cells after intracoronary or intravenous injection in pigs subjected to acute myocardial infarction with subsequent reperfusion. Cardiovasc Revasc Med 8 (2007) 21-27
8. Hansen A., Wolf D., Reinhard A., Katus H.A., Kuecherer H., and Hansen A. Dose-dependent effects of intravenous allogeneic mesenchymal stem cells in the infarcted porcine heart. Stem Cells Dev 18 (2009) 321-329
9. Hashemi S.M., Ghods S., Kolodgie F.D., et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 29 (2008) 251-259
10. Hou D., Youssef E.A., Brinton T.J., et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112 (2005) I150-I156
11. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
12. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95 (2004) 9-20
13. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
14. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
15. Barkhausen J., Hunold P., Jochims M., and Debatin J.F. Imaging of myocardial perfusion with magnetic resonance. J Magn Reson Imaging 19 (2004) 750-757
16. Nagel E., Klein C., Paetsch I., et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108 (2003) 432-437
17. de Silva R., Raval A.N., Hadi M., et al. Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product might not improve remodeling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur Heart J 29 (2008) 1772-1782
18. Ramos G.A., and Hare J.M. Cardiac cell-based therapy: cell types and mechanisms of actions. Cell Transplant 16 (2007) 951-961
19. Mazhari R., and Hare J.M. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 4 Suppl 1 (2007) S21-S26
20. Bartunek J., Croissant J.D., Wijns W., et al. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol 292 (2007) H1095-H1104
21. Ly H.Q., Hoshino K., Pomerantseva I., et al. In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction. Eur Heart J 30 (2009) 2861-2868
22. Huikuri H.V., Kervinen K., Niemela M., et al. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 29 (2008) 2723-2732
23. Tendera M., Wojakowski W., Ruzyllo W., et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 30 (2009) 1313-1321
24. Pipp F., Heil M., Issbrucker K., et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 92 (2003) 378-385
25. Roncal C., Buysschaert I., Chorianopoulos E., et al. Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance. J Pathol 216 (2008) 236-244
26. Marsboom G., and Janssens S. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. Expert Rev Cardiovasc Ther 6 (2008) 687-701
27. Bogaert J., Kalantzi M., Rademakers F.E., Dymarkowski S., and Janssens S. Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 17 (2007) 2572-2580
28. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102 (2005) 11474-11479
29. Schuleri K.H., Amado L.C., Boyle A.J., et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 294 (2008) H2002-H2011